Symbol
Xilio Therapeutics, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$1.07
Current price of the stock
$2M
Trading volume of the stock
$67.9M
Market capitalization of the company
Micro Cap
Category of market capitalization
-
Long-term growth mean estimate
5.00
Mean analyst rating
-
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
1.67
Current ratio
100.00%
Gross profit margin
-652.32%
Operating profit margin
-652.32%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-619.53%
Pretax profit margin
-619.53%
Net profit margin
-66.84%
Measures profitability relative to shareholders' equity
-66.84%
ROE excluding intangible assets
-18.78%
Measures profitability relative to total assets
-66.84%
Measures profitability relative to invested capital
0.03
Asset turnover ratio
-
Inventory turnover ratio
-
Receivables turnover ratio
-
Average number of days it takes to collect receivables
-0.62
Measures valuation relative to earnings
-
P/E based on future earnings estimates
14.70
Measures valuation relative to sales
2.24
Measures valuation relative to book value
-0.39
Measures valuation relative to operating cash flow
-0.38
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
